Award details

Targeting influenza vaccine antigens to antigen presenting cells (APC)

ReferenceBBS/E/I/00001287
Principal Investigator / Supervisor Dr Colin Butter
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 367,944
StatusCompleted
TypeInstitute Project
Start date 01/07/2006
End date 30/06/2009
Duration36 months

Abstract

The targeting of vaccine antigens to dendritic cells is used to provoke stronger and faster immune responses than are achieved with conventional vaccines. Although these outcomes are highly desirable this approach has not been reported in poultry, primarily due to a lack of appropriate APC-specific reagents. The recent cloning of APC-specific molecules under (amongst others) CSG projects 1033-BC-I-C, 1031-YJ-I-C and Intervet-funded project 0907-YJ-I-C have now provided these tools. This project will apply them to the potentiation of vaccination against avian influenza (AI) virus. Molecules will include both monoclonal antibodies and fusion proteins with specificity for APCs. Initially these will be linked with relevant avian influenza virus antigens, and used to vaccinate chicks. Cellular and humoral immune responses will be measured and chicks challenged with low and high pathogenicity avian influenza virus to determine efficacy. Once proof of principal for a particular vaccine antigen / target molecule is established attention will be given to delivery systems and routes. It is anticipated that this project will provide preliminary data that will be used in further funding applications, including approaches to industrial partners.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsAnimal Health, Immunology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file